Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Wang, Yixiang ^a   Radfar, Soroosh ^b   Liu, Suhu ^c   Riker, Adam I ^d   Khong, Hung T ^e  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d Ochsner Cancer Institute   (United States)

^e UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR M; UNCLASSIFIED DRUG; ISOPROTEIN; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE DELETION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; MELANOCYTE; NUCLEOTIDE SEQUENCE; OVARY CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA; SPLICEOSOME; AMINO ACID SEQUENCE; BLOOD; GENE EXPRESSION PROFILING; GENETICS; MELANOMA; METABOLISM; MOLECULAR GENETICS; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION PROFILING; HUMANS; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE DELETION; TUMOR MARKERS, BIOLOGICAL;

EID: 77949459989     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-14     Document Type: Article

References (30)

1. Goding CR. Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 2000, 14:1712-1728.
2. Tachibana M. MITF: a stream flowing for pigment cells. Pigment Cell Res 2000, 13:230-240. 10.1034/j.1600-0749.2000.130404.x, 10952390.
3. Shibahara S, Takeda K, Yasumoto K, Udono T, Watanabe K, Saito H, Takahashi K. Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J Investig Dermatol Symp Proc 2001, 6:99-104. 10.1046/j.0022-202x.2001.00010.x, 11764295.
4. Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA, Arnheiter H. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 1993, 74:395-404. 10.1016/0092-8674(93)90429-T, 8343963.
5. Steingrimsson E, Moore KJ, Lamoreux ML, Ferre-D'Amare AR, Burley SK, Zimring DC, Skow LC, Hodgkinson CA, Arnheiter H, Copeland NG, Jenkins NA. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet 1994, 8:256-263. 10.1038/ng1194-256, 7874168.
6. Hughes AE, Newton VE, Liu XZ, Read AP. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat Genet 1994, 7:509-512. 10.1038/ng0894-509, 7951321.
7. Amiel J, Watkin PM, Tassabehji M, Read AP, Winter RM. Mutation of the MITF gene in albinism-deafness syndrome (Tietz syndrome). Clin Dysmorphol 1998, 7:17-20. 10.1097/00019605-199801000-00003, 9546825.
8. Smith SD, Kelley PM, Kenyon JB, Hoover D. Tietz syndrome (hypopigmentation/deafness) caused by mutation of MITF. J Med Genet 2000, 37:446-448. 10.1136/jmg.37.6.446, 1734605, 10851256.
9. Amae S, Fuse N, Yasumoto K, Sato S, Yajima I, Yamamoto H, Udono T, Durlu YK, Tamai M, Takahashi K, Shibahara S. Identification of a novel isoform of microphthalmia-associated transcription factor that is enriched in retinal pigment epithelium. Biochem Biophys Res Commun 1998, 247:710-715. 10.1006/bbrc.1998.8838, 9647758.
10. Udono T, Yasumoto K, Takeda K, Amae S, Watanabe K, Saito H, Fuse N, Tachibana M, Takahashi K, Tamai M, Shibahara S. Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters. Biochim Biophys Acta 2000, 491:205-219.
11. Fuse N, Yasumoto K, Takeda K, Amae S, Yoshizawa M, Udono T, Takahashi K, Tamai M, Tomita Y, Tachibana M, Shibahara S. Molecular cloning of cDNA encoding a novel microphthalmia-associated transcription factor isoform with a distinct amino-terminus. J Biochem 1999, 126:1043-1051.
12. Takeda K, Yasumoto K, Kawaguchi N, Udono T, Watanabe K, Saito H, Takahashi K, Noda M, Shibahara S. Mitf-D, a newly identified isoform, expressed in the retinal pigment epithelium and monocyte-lineage cells affected by Mitf mutations. Biochim Biophys Acta 2002, 1574:15-23.
13. Oboki K, Morii E, Kataoka TR, Jippo T, Kitamura Y. Isoforms of mi transcription factor preferentially expressed in cultured mast cells of mice. Biochem Biophys Res Commun 2002, 290:1250-1254. 10.1006/bbrc.2002.6332, 11811997.
14. Shibahara S, Yasumoto K, Amae S, Fuse N, Udono T, Takahashi K. Implications of isoform multiplicity of microphthalmia-associated transcription factor in the pathogenesis of auditory-pigmentary syndromes. J Investig Dermatol Symp Proc 1999, 4:101-104.
15. Hershey CL, Fisher DE. Genomic analysis of the Microphthalmia locus and identification if MITF-J/Mitf-J isoform. Gene 2005, 347:73-82. 10.1016/j.gene.2004.12.002, 15715979.
16. Vachtenheim J, Borovansky J. Microphthalmia transcription factor: a specific marker for malignant melanoma. Prague Med Rep 2004, 105:318-324.
17. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005, 436:117-122. 10.1038/nature03664, 16001072.
18. King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for Melanoma Diagnosis. Am J Pathol 1999, 155:731-738. 1866880, 10487831.
19. Tsao H, Nadiminti U, Sober AJ, Bigby M. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. Arch Dermatol 2001, 137:325-330.
20. Salti GI, Manougian T, Farolan M, Shilkaitis A, Majumdar D, Das Gupta TK. Microphthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. Cancer Res 2000, 60:5012-5016.
21. Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Kuo C, Wang HJ, Milford R, Morton DL, Hoon DS. Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clin Cancer Res 2006, 12:1137-1143. 10.1158/1078-0432.CCR-05-1847, 16489066.
22. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008, 1:13-28. 10.1186/1755-8794-1-13, 2408576, 18442402.
23. von Goessel H, Hossle JP, Seger R, Gungor T. Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene. Exp Hematol 2006, 34:528-535. 10.1016/j.exphem.2006.01.005, 16569599.
24. Steingrimsson E, Moore KJ, Lamoreux ML, Ferre-D'Amare AR, Burley SK, Zimring DC, Skow LC, Hodgkinson CA, Arnheiter H, Copeland NG, Jenkins NA. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nature Genet 1994, 8:256-263. 10.1038/ng1194-256, 7874168.
25. Arnheiter H, Hou L, Nguyen MT, Bismuth K, Csermely T, Murakami H, Skuntz S, Liu W, Bharti K. MITF: A matter of life and death developing melanocytes. From Melanocytes to Melanoma: The Progression to Malignancy 2006, 27-50. New Jersey: Humana Press, Hearing VJ, Leong SP.
26. Moller A, Eysteinsson T, Steingrimsson E. Electroretinographic assessment of retinal function in microphthalmia mutant mice. Exp Eye Res 2004, 18:837-848.
27. Bismuth K, Skuntz S, Hallsson JH, Pak E, Dutra AS, Steingrimsson E, Arnheiter H. An unstable targeted allele of the mouse Mitf gene with a high somaticand germline reversion rate. Genetics 2008, 178:259-272. 10.1534/genetics.107.081893, 2206076, 18202372.
28. Bauer GL, Praetorius C, Bergsteinsdóttir K, Hallsson JH, Gísladóttir BK, Schepsky A, Swing DA, O'Sullivan TN, Arnheiter H, Bismuth K, et al. The role of MITF phosphorylation sites during coat color and eye development in mice analyzed by BAC transgene rescue. Genetics 2009, 183:581-94. 10.1534/genetics.109.103945, 2766318, 19635938.
29. Khong HT, Rosenberg SA. The Waardenburg syndrome type 4 gene, SOX10, is a novel tumor-associated antigen identified in a patient with a dramatic response to immunotherapy. Cancer Res 2002, 62:3020-3. 2561957, 12036907.
30. Schmidt H, Sorensen BS, Maase H, Bang C, Agger R, Hokland M, Nexo E. Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma. Melanoma Res 2002, 12:585-592. 10.1097/00008390-200212000-00008, 12459648.